Host F1 mice pretreated with granulocyte colony-stimulating factor accept parental bone marrow grafts in hybrid resistance system

Blood

Volumn 89, Issue 4, 1997, Pages 1446-1451

  Iizuka, Koho ^a   Kaneko, Hideo ^a   Yamada, Taketo ^a   Kimura, Hiromitsu ^a   Kokai, Yasuo ^a   Fujimoto, Junichiro ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; GENE EXPRESSION; HEMATOPOIESIS; HISTOCOMPATIBILITY; HOST; HYBRIDIZATION; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031043510     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1446     Document Type: Article

References (34)

1. Metcalf D: The Florey Lecture, 1991. The colony-stimulating factors: Discovery to clinical use. Phil Trans R Soc Lond Biol 333:147, 1991
2. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
3. Bolwell BJ, Fishleder A, Andersen SW, Lichtin AE, Koo A, Yanssens T, Burwell R, Baucco P, Green R: G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: Parameters affecting bone marrow engraftment. Bone Marrow Transplant 12:609, 1993
4. Dreger P, Suttorp M, Haferlach T, Loffler H, Schmitz N, Schroyens W: Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404, 1993
5. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LW, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral biood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995
6. Russell NH, Hunter A, Rogers S, Hanley J, Anderson D: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 341:1482, 1993
7. Yamada T, Kaneko H, Iizuka K, Matsubayashi Y, Kokai Y, Fujimoto J: Elevation of lymphocyte and hematopoietic stem cell numbers in mice transgenic for human granulocyte CSF. Lab Invest 74:384, 1996
8. Taga T, Kariya Y, Shimada M, Uchida A: Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: Roll of granulocyte colony-stimulating factor. Immunol Lett 39:65, 1994
9. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JLM: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86:4422, 1995
10. Lee MY, Fevold KL, Dorshkind K, Fukunaga R, Nagata S, Rosse C: In vivo and in vitro suppression of primary B lymphocytopoiesis by tumor-derived and recombinant granulocyte colony-stimulating factor. Blood 82:2062, 1993
11. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, Miura AB: Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-α production. Blood 86:2220, 1995
12. Kokai Y, Kaneko H, Iizuka K, Matsuura A, Fujimoto J: Inhibition of resistance to hematopoietic allo-grafts in granulocyte colony-stimulating factor transgenic mice. Eur J Immunol 26:115, 1996
13. Dorshkind K: In vivo administration of recombinant granulocyte-macrophage colony-stimulating factor results in a reversible inhibition of primary B lymphopoiesis. J Immunol 146:4204, 1991
14. Yu YY, Kumar V, Bennett M: Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 10:189, 1992
15. Cudkowicz G, Stimpfling JH: Deficient growth of C57BL marrow cells transplanted in F1 hybrid mice. Association with the histocompatibility-2 locus. Immunology 7:291, 1964
16. Kasai M, Yoneda T, Habu S, Maruyama Y, Okumura K, Tokunaga T: In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature 291:334. 1981
17. Bramwell NH, Burns BF: The effects of fixative type and fixation time on the quantity and quality of extractable DNA for hybridization studies on lymphoid tissue. Exp Hematol 16:730, 1988
18. Gubbay J, Collignon J, Koopman P, Capel B, Economou A, Munsterberg A, Vivian N, Goodfellow P, Lovell-Badge R: A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 346:245, 1990
19. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S: Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res 14:2829, 1986
20. Ikebuchi K, Ihle JN, Hirai Y, Wong GG, Clark SC, Ogawa M: Synergistic factors for stem cell proliferation: Further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor. Blood 72:2007, 1988
21. Bungart B, Loeffler M, Goris H, Dontje B, Diehl V, Nijhof W: Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 76:174, 1990
22. Demetri GD, Griffin JD: Granulocyte colony-stimulating factor and its receptor. Blood 78:2791, 1991
23. Korbling M, Przepiorka D, Huh YO, Engel H, van-Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M. Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
24. Molina L, Chabannon C, Viret F, Moine A, Leger J, Nicolini F, Hollard D, Sotto JJ: Granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood stem cells for rescue graft failure after allogeneic bone marrow transplantation in two patients with acute myeloblastic leukemia in first complete remission. Blood 85:1678, 1995
25. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
26. Weaver CH, Longin K, Buckner CD, Bensinger W: Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 13:411, 1994
27. Kaneko H, Fujimoto J, Iizuka K, Kimura H, Kokai Y: Engraftment of rat bone marrow cells in mice transgenic for granulocyte-colony stimulating factor. Transplant Proc 27:1551, 1995
28. Tamura M, Hattori K, Nomura H, Oheda M, Kubota N, Imazeki I, Ono M, Ueyama Y, Nagata S, Shirafuji N, Asano A: Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). Biochem Biophys Res Commun 142:454, 1987
29. Drize N, Gan O, Zander A: Effect of recombinant human granulocyte colony-stimulating factor treatment of mice on spleen colony-forming unit number and self-renewal capacity. Exp Hematol 21:1289, 1993
30. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074, 1988
31. Yokoyama WM: Hybrid resistance and the Ly-49 family of natural killer cell receptors. J Exp Med 182:273, 1995
32. Ohlen C, Kling G, Hoglund P, Hansson M, Scangos G, Bieberich C, Jay G, Karre K: Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246:666, 1989
33. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D: MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199, 1991
34. Brennan J, Mager D, Jefferies W, Takei F: Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 180:2287, 1994